United States v. James Dolan; Proposed Final Judgment and Competitive Impact Statement, 64359-64364 [2018-27055]
Download as PDF
Federal Register / Vol. 83, No. 240 / Friday, December 14, 2018 / Notices
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: December 10, 2018.
Lisa Barton,
Secretary to the Commission.
United States of America, c/o Department
of Justice,
Washington, D.C. 20530, Plaintiff, v. James L.
Dolan, c/o The Madison Square Garden
Company, Two Penn Plaza, New York, NY
10121, Defendant.
Civil Action No. 1:18-cv-02858
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Antitrust Division
amozie on DSK3GDR082PROD with NOTICES1
United States v. James Dolan;
Proposed Final Judgment and
Competitive Impact Statement
Notice is hereby given pursuant to the
Antitrust Procedures and Penalties Act,
15 U.S.C. 16(b)–(h), that a proposed
Final Judgment, Stipulation, and
Competitive Impact Statement have
been filed with the United States
District Court for the District of
Columbia in United States of America v.
James Dolan, Civil Action No. 1:18–cv–
02858. On December 6, 2018, the United
States filed a Complaint alleging that
James Dolan violated the notice and
waiting period requirements of the HartScott-Rodino Antitrust Improvements
Act of 1976, 15 U.S.C. 18a, with respect
to his acquisition of voting securities of
Madison Square Garden Company. The
proposed Final Judgment, filed at the
same time as the Complaint, requires
James Dolan to pay a civil penalty of
$609,810.
Copies of the Complaint, proposed
Final Judgment, and Competitive Impact
Statement are available for inspection
on the Antitrust Division’s website at
https://www.justice.gov/atr and at the
Office of the Clerk of the United States
District Court for the District of
Columbia. Copies of these materials may
be obtained from the Antitrust Division
upon request and payment of the
copying fee set by Department of Justice
regulations.
2 All contract personnel will sign appropriate
nondisclosure agreements.
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
16:57 Dec 13, 2018
Patricia A. Brink,
Director of Civil Enforcement.
United States District Court for the
District of Columbia
[FR Doc. 2018–27087 Filed 12–13–18; 8:45 am]
VerDate Sep<11>2014
Public comment is invited within 60
days of the date of this notice. Such
comments, including the name of the
submitter, and responses thereto, will be
posted on the Antitrust Division’s
website, filed with the Court, and, under
certain circumstances, published in the
Federal Register. Comments should be
directed to Roberta S. Baruch, Special
Attorney, United States, c/o Federal
Trade Commission, 600 Pennsylvania
Avenue NW, CC–8416, Washington, DC
20580 (telephone: 202–326–2861;
e-mail: rbaruch@ftc.gov).
Jkt 247001
COMPLAINT FOR CIVIL PENALTIES
FOR FAILURE TO COMPLY WITH THE
PREMERGER REPORTING AND
WAITING REQUIREMENTS OF THE
HART-SCOTT RODINO ACT
The United States of America,
Plaintiff, by its attorneys, acting under
the direction of the Attorney General of
the United States and at the request of
the Federal Trade Commission, brings
this civil antitrust action to obtain
monetary relief in the form of civil
penalties against Defendant James L.
Dolan (‘‘Dolan’’). Plaintiff alleges as
follows:
NATURE OF THE ACTION
1. Dolan violated the notice and
waiting period requirements of the HartScott-Rodino Antitrust Improvements
Act of 1976, 15 U.S.C. § 18a (‘‘HSR Act’’
or ‘‘Act’’), with respect to the
acquisition of voting securities of the
Madison Square Garden Company
(‘‘MSG’’) in 2017.
JURISDICTION AND VENUE
2. This Court has jurisdiction over the
subject matter of this action pursuant to
Section 7A(g) of the Clayton Act, 15
U.S.C. § 18a(g), and pursuant to 28
U.S.C. §§ 1331, 1337(a), 1345, and 1355
and over the Defendant by virtue of
Defendant’s consent, in the Stipulation
relating hereto, to the maintenance of
this action and entry of the Final
Judgment in this District.
3. Venue is properly based in this
District by virtue of Defendant’s
consent, in the Stipulation relating
hereto, to the maintenance of this action
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
64359
and entry of the Final Judgment in this
District.
THE DEFENDANT
4. Defendant Dolan is a natural person
with his principal office and place of
business at Two Penn Plaza, New York,
NY 10121. Dolan is engaged in
commerce, or in activities affecting
commerce, within the meaning of
Section 1 of the Clayton Act, 15 U.S.C.
§ 12, and Section 7A(a)(1) of the Clayton
Act, 15 U.S.C. § 18a(a)(1). At all times
relevant to this complaint, Dolan had
sales or assets in excess of $161.5
million.
OTHER ENTITY
5. MSG is a corporation organized
under the laws of Delaware with its
principal place of business at Two Penn
Plaza, New York, NY 10121. MSG is
engaged in commerce, or in activities
affecting commerce, within the meaning
of Section 1 of the Clayton Act, 15
U.S.C. § 12, and Section 7A(a)(1) of the
Clayton Act, 15 U.S.C. § 18a(a)(1). At all
times relevant to this complaint, MSG
had sales or assets in excess of $16.6
million.
THE HART-SCOTT-RODINO ACT AND
RULES
6. The HSR Act requires certain
acquiring persons and certain persons
whose voting securities or assets are
acquired to file notifications with the
Department of Justice and the Federal
Trade Commission (collectively, the
‘‘federal antitrust agencies’’) and to
observe a waiting period before
consummating certain acquisitions of
voting securities or assets. 15 U.S.C.
§ 18a(a) and (b). These notification and
waiting period requirements apply to
acquisitions that meet the HSR Act’s
thresholds, which have been adjusted
annually since 2004. The size of
transaction threshold is $50 million, as
adjusted ($80.8 million for most of
2017). In addition, there is a separate
filing requirement for transactions in
which the acquirer will hold voting
securities in excess of $100 million, as
adjusted ($161.5 million in 2017), and
for transactions in which the acquirer
will hold voting securities in excess of
$500 million, as adjusted ($807.5
million in 2017). With respect to the
size of person thresholds, the HSR Act
requires one person involved in the
transaction to have sales or assets in
excess of $10 million, as adjusted ($16.6
million in 2017), and the other person
to have sales or assets in excess of $100
million, as adjusted ($161.5 million in
2017).
7. The HSR Act’s notification and
waiting period requirements are
E:\FR\FM\14DEN1.SGM
14DEN1
64360
Federal Register / Vol. 83, No. 240 / Friday, December 14, 2018 / Notices
amozie on DSK3GDR082PROD with NOTICES1
intended to give the federal antitrust
agencies prior notice of, and
information about, proposed
transactions. The waiting period is also
intended to provide the federal antitrust
agencies with an opportunity to
investigate a proposed transaction and
to determine whether to seek an
injunction to prevent the consummation
of a transaction that may violate the
antitrust laws.
8. Pursuant to Section (d)(2) of the
HSR Act, 15 U.S.C. § 18a(d)(2), rules
were promulgated to carry out the
purposes of the HSR Act. 16 C.F.R.
§§ 801–03 (‘‘HSR Rules’’). The HSR
Rules, among other things, define terms
contained in the HSR Act.
9. Pursuant to section 801.13(a)(1) of
the HSR Rules, 16 C.F.R. § 801.13(a)(1),
‘‘all voting securities of [an] issuer
which will be held by the acquiring
person after the consummation of an
acquisition’’—including any held before
the acquisition—are deemed held ‘‘as a
result of’’ the acquisition at issue.
10. Pursuant to sections 801.13(a)(2)
and 801.10(c)(1) of the HSR Rules, 16
C.F.R. § 801.13(a)(2) and § 801.10(c)(1),
the value of voting securities already
held is the market price, defined to be
the lowest closing price within 45 days
prior to the subsequent acquisition.
11. Section 802.21 of the HSR Rules,
16 C.F.R. § 802.21, provides that once a
person has filed under the HSR Act and
the waiting period has expired, the
person can acquire additional voting
securities of the issuer without making
a new filing for five years from the
expiration of the waiting period, so long
as the holdings do not exceed a higher
threshold than was indicated in the
filing.
12. Section 7A(g)(1) of the Clayton
Act, 15 U.S.C. § 18a(g)(1), provides that
any person, or any officer, director, or
partner thereof, who fails to comply
with any provision of the HSR Act is
liable to the United States for a civil
penalty for each day during which such
person is in violation. Pursuant to the
Federal Civil Penalties Inflation
Adjustment Act Improvements Act of
2015, Pub. L. 114–74, § 701 (further
amending the Federal Civil Penalties
Inflation Adjustment Act of 1990), and
Federal Trade Commission Rule 1.98, 16
C.F.R. § 1.98, 83 Fed. Reg. 2902 (January
22, 2018), the maximum amount of civil
penalty is currently $41,484 per day.
DEFENDANT’S PRIOR VIOLATION OF
THE HSR ACT
13. On March 10, 2010, Dolan
acquired voting securities of Cablevision
Systems Corporation (‘‘CVC’’) that
resulted in holdings exceeding the
adjusted $50 million threshold then in
VerDate Sep<11>2014
18:42 Dec 13, 2018
Jkt 247001
effect under the HSR Act. Although he
was required to do so, Dolan did not file
under the HSR Act prior to acquiring
CVC voting securities on March 10,
2010.
14. Subsequently, Dolan made
additional acquisitions of CVC voting
securities such that on November 30,
2010 his holdings exceeded the adjusted
$100 million threshold then in effect
under the HSR Act. Although he was
required to do so, Dolan did not file
under the HSR Act prior to making the
acquisition of CVC voting securities on
November 30, 2010.
15. On February 24, 2012, Dolan made
a corrective filing under the HSR Act for
the acquisitions of CVC voting
securities. In a letter accompanying the
corrective filing, Dolan acknowledged
that the transactions were reportable
under the HSR Act, but asserted that the
failure to file and observe the waiting
period was inadvertent.
16. On May 4, 2012, the Premerger
Notification Office of the Federal Trade
Commission sent a letter to Dolan
indicating that it would not recommend
a civil penalty action regarding the
March 10, 2010, and November 30,
2010, CVC acquisitions. The letter
advised, however, that Dolan ‘‘still must
bear responsibility for compliance with
the Act’’ and was ‘‘accountable for
instituting an effective program to
ensure full compliance with the Act’s
requirements.’’
DEFENDANT’S VIOLATION OF THE
HSR ACT
17. Dolan is the Executive Chairman
and a Director of MSG and, as a result
of holding these positions, frequently
receives restricted stock units (‘‘RSUs’’)
as a part of his compensation package.
On August 16, 2016, due to vesting
RSUs, Dolan filed an HSR Notification
for an acquisition of MSG voting
securities that would result in holdings
exceeding the $50 million threshold as
adjusted. Early termination of the HSR
Act’s waiting period was granted on this
filing on September 6, 2016, and Dolan
completed the acquisition three days
later. Dolan was permitted under the
HSR Act to acquire additional voting
securities of MSG without making
another HSR Act filing so long as he did
not exceed the $100 million threshold,
as adjusted. As of February 27, 2017, the
adjusted $100 million threshold was
$161.5 million.
18. On September 11, 2017, Dolan
acquired 591 shares of MSG due to
vesting RSUs. As a result of this
acquisition, Dolan held voting securities
of MSG valued in excess of the $161.5
million threshold then in effect.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
19. Although required to do so, Dolan
did not file under the HSR Act or
observe the HSR Act’s waiting period
prior to completing the September 11,
2017, transaction.
20. On November 24, 2017, Dolan
made a corrective filing and the waiting
period expired on December 26, 2017.
Dolan was in continuous violation of
the HSR Act from September 11, 2017,
when he acquired the MSG voting
securities valued in excess of the HSR
Act’s then applicable $100 million filing
threshold, as adjusted ($161.5 million),
through December 26, 2017, when the
waiting period expired on his corrective
filing.
REQUESTED RELIEF
WHEREFORE, Plaintiff requests:
a. That the Court adjudge and decree
that Defendant’s acquisition of MSG
voting securities on September 11, 2017,
was a violation of the HSR Act, 15
U.S.C. § 18a; and that Defendant was in
violation of the HSR Act each day from
September 11, 2017, through December
26, 2017;
b. That the Court order Defendant to
pay to the United States an appropriate
civil penalty as provided by the HSR
Act, 15 U.S.C. § 18a(g)(1), and the
Federal Civil Penalties Inflation
Adjustment Act Improvements Act of
2015, Pub. L. 114–74, § 701 (further
amending the Federal Civil Penalties
Inflation Adjustment Act of 1990), and
Federal Trade Commission Rule 1.98, 16
C.F.R. § 1.98, 83 Fed. Reg. 2902 (January
22, 2018);
c. That the Court order such other and
further relief as the Court may deem just
and proper; and
d. That the Court award Plaintiff its
costs of this suit.
Dated:
lllllllllllllllllllll
FOR THE PLAINTIFF UNITED STATES
OF AMERICA:
lllllllllllllllllllll
Makin Delrahim,
D.C. Bar No. 457795,
Assistant Attorney General,
Department of Justice,
Antitrust Division,
Washington, D.C. 20530
lllllllllllllllllllll
Roberta S. Baruch,
D.C. Bar No. 269266,
Special Attorney.
lllllllllllllllllllll
Kenneth A. Libby,
Special Attorney.
lllllllllllllllllllll
Jennifer Lee,
Special Attorney,
Federal Trade Commission,
E:\FR\FM\14DEN1.SGM
14DEN1
Federal Register / Vol. 83, No. 240 / Friday, December 14, 2018 / Notices
Washington, D.C. 20530,
(202) 326–2694.
United States District Court for the
District of Columbia
United States of America, Plaintiff, v.
James L. Dolan, Defendant.
Civil Action No. 1:18-cv-02858
amozie on DSK3GDR082PROD with NOTICES1
[PROPOSED] FINAL JUDGMENT
Plaintiff, the United States of
America, having commenced this action
by filing its Complaint herein for
violation of Section 7A of the Clayton
Act, 15 U.S.C. § 18a, commonly known
as the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, and Plaintiff
and Defendant James L. Dolan, by their
respective attorneys, having consented
to the entry of this Final Judgment
without trial or adjudication of any
issue of fact or law herein, and without
this Final Judgment constituting any
evidence against or an admission by the
Defendant with respect to any such
issue:
NOW, THEREFORE, before the taking
of any testimony and without trial or
adjudication of any issue of fact or law
herein, and upon the consent of the
parties hereto, it is hereby
ORDERED, ADJUDGED, AND
DECREED:
The Court has jurisdiction of the
subject matter of this action and of the
Plaintiff and the Defendant. The
Complaint states a claim upon which
relief can be granted against the
Defendant under Section 7A of the
Clayton Act, 15 U.S.C. § 18a.
II.
Judgment is hereby entered in this
matter in favor of Plaintiff and against
Defendant, and, pursuant to Section
7A(g)(1) of the Clayton Act, 15 U.S.C.
§ 18a(g)(1), the Debt Collection
Improvement Act of 1996, Pub. L.
104-134 § 31001(s) (amending the
Federal Civil Penalties Inflation
Adjustment Act of 1990, 28 U.S.C.
§ 2461), the Federal Civil Penalties
Inflation Adjustment Act Improvements
Act of 2015, Pub. L. 114–74 § 701
(further amending the Federal Civil
Penalties Inflation Adjustment Act of
1990), and Federal Trade Commission
Rule 1.98, 16 C.F.R. § 1.98, 82 Fed. Reg.
8135 (January 24, 2017), Defendant is
hereby ordered to pay a civil penalty in
the amount of six hundred nine
thousand eight hundred and ten dollars
($609,810). Payment of the civil penalty
ordered hereby shall be made by wire
transfer of funds or cashier’s check. If
the payment is made by wire transfer,
Defendant shall contact Janie Ingalls of
the Antitrust Division’s Antitrust
Documents Group at (202) 514–2481 for
VerDate Sep<11>2014
18:42 Dec 13, 2018
Jkt 247001
64361
instructions before making the transfer.
If the payment is made by cashier’s
check, the check shall be made payable
to the United States Department of
Justice and delivered to: Janie Ingalls,
United States Department of Justice,
Antitrust Division, Antitrust Documents
Group, 450 5th Street, NW, Suite 1024,
Washington, D.C. 20530
Defendant shall pay the full amount
of the civil penalty within thirty (30)
days of entry of this Final Judgment. In
the event of a default or delay in
payment, interest at the rate of eighteen
(18) percent per annum shall accrue
thereon from the date of the default or
delay to the date of payment.
related to Dolan’s acquisitions of voting
securities of the Madison Square Garden
Company (‘‘MSG’’) in September 2017.
The Complaint alleges that Dolan
violated Section 7A of the Clayton Act,
15 U.S.C. § 18a, commonly known as
the Hart-Scott-Rodino Antitrust
Improvements Act of 1976 (the ‘‘HSR
Act’’). The HSR Act provides that ‘‘no
person shall acquire, directly or
indirectly, any voting securities of any
person’’ exceeding certain thresholds
until that person has filed preacquisition notification and report forms
with the Department of Justice and the
Federal Trade Commission (collectively,
the ‘‘federal antitrust agencies’’ or
‘‘agencies’’) and the post-filing waiting
III.
period has expired. 15 U.S.C. § 18a(a). A
Each party shall bear its own costs of
key purpose of the notification and
this action.
waiting period requirements is to
protect consumers and competition
IV.
from potentially anticompetitive
This Final Judgment shall expire
transactions by providing the agencies
upon payment in full by the Defendant
an opportunity to conduct an antitrust
of the civil penalty required by Section
review of proposed transactions before
II of this Final Judgment.
they are consummated.
The Complaint alleges that Dolan
V.
acquired voting securities of MSG in
Entry of this Final Judgment is in the
excess of then-applicable statutory
public interest. The parties have
threshold ($161.5 million at the time of
complied with the requirements of the
acquisition) without making the
Antitrust Procedures and Penalties Act,
required pre-acquisition HSR Act filings
15 U.S.C. § 16, including making copies
with the agencies and without observing
available to the public of this Final
the waiting period, and that Dolan and
Judgment, the Competitive Impact
MSG met the applicable statutory size of
Statement, and any comments thereon
person thresholds.
and the United States’ responses to
At the same time the Complaint was
comments. Based upon the record
filed
in the present action, the United
before the Court, which includes the
States also filed a Stipulation and
Competitive Impact Statement and any
proposed Final Judgment that
comments and response to comments
eliminates the need for a trial in this
filed with the Court, entry of this Final
case. The proposed Final Judgment is
Judgment is in the public interest.
designed to address the violation
Dated:
lllllllllllllllllllll alleged in the Complaint and deter
Dolan’s HSR Act violations. Under the
United States District Judge
proposed Final Judgment, Dolan must
UNITED STATES DISTRICT COURT
pay a civil penalty to the United States
FOR THE DISTRICT OF COLUMBIA
in the amount of $609,810.
The United States and the Defendant
United States of America, Plaintiff, v. James
have stipulated that the proposed Final
L. Dolan, Defendant.
Judgment may be entered after
Civil Action No. 1:18-cv-02858
compliance with the APPA, unless the
COMPETITIVE IMPACT STATEMENT
United States first withdraws its
consent. Entry of the proposed Final
Plaintiff United States of America
Judgment would terminate this case,
(‘‘United States’’), pursuant to Section
except that the Court would retain
2(b) of the Antitrust Procedures and
jurisdiction to construe, modify, or
Penalties Act (‘‘APPA’’), 15 U.S.C.
§ 16(b)-(h), files this Competitive Impact enforce the provisions of the proposed
Statement relating to the proposed Final Final Judgment and punish violations
thereof.
Judgment submitted for entry in this
civil antitrust proceeding.
II. DESCRIPTION OF THE EVENTS
I. NATURE AND PURPOSE OF THE
PROCEEDING
GIVING RISE TO THE ALLEGED
VIOLATION
On December 6, 2018, the United
States filed a Complaint against
Defendant James L. Dolan (‘‘Dolan’’),
Dolan is the Executive Chairman and
a Director of MSG and an investor. At
all times relevant to the Complaint,
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
E:\FR\FM\14DEN1.SGM
14DEN1
amozie on DSK3GDR082PROD with NOTICES1
64362
Federal Register / Vol. 83, No. 240 / Friday, December 14, 2018 / Notices
Dolan had sales or assets in excess of
$161.5 million. At all times relevant to
the Complaint, MSG had sales or assets
in excess of $16.6 million.
In his roles as Executive Chairman
and Director of MSG, Dolan frequently
receives restricted stock units (‘‘RSUs’’)
as a part of his compensation package.
On August 16, 2016, due to the
imminent vesting of RSUs, Dolan made
an HSR filing for an acquisition of MSG
voting securities that would result in
holdings exceeding the adjusted $50
million threshold then in effect. The
Premerger Notification Office granted
early termination on this filing on
September 6, 2016, and Dolan
completed the acquisition three days
later. For a period of five years, Dolan
was permitted under the HSR Act to
acquire additional voting securities of
MSG without making another HSR Act
filing so long as he did not exceed the
$100 million threshold, as adjusted. As
of February 27, 2017, the adjusted $100
million threshold was $161.5 million.
On September 11, 2017, Dolan
acquired 591 shares of MSG due to
vesting RSUs. As a result of this
acquisition, Dolan held voting securities
of MSG valued in excess of the $161.5
million threshold then in effect.
Although he was required to do so,
Dolan did not file under the HSR Act or
observe the HSR Act’s waiting period
prior to completing the September 11,
2017, transaction.
Dolan made a corrective HSR Act
filing on November 27, 2017, after
learning that this acquisition was
subject to the HSR Act’s requirements
and that he was obligated to file. The
waiting period for that corrective filing
expired on December 26, 2017.
The Complaint further alleges that
Dolan’s September 2017 HSR Act
violation was not the first time Dolan
had failed to observe the HSR Act’s
notification and waiting period
requirements. On March 10, 2010, Dolan
acquired voting securities of Cablevision
Systems Corporation (‘‘CVC’’) that
resulted in holdings exceeding the
adjusted $50 million threshold then in
effect under the HSR Act. Although he
was required to do so, Dolan did not file
under the HSR Act prior to acquiring
CVC voting securities on March 10,
2010. Subsequently, Dolan made
additional acquisitions of CVC voting
securities such that on November 30,
2010 his holdings exceeded the adjusted
$100 million threshold then in effect
under the HSR Act. Although he was
required to do so, Dolan did not file
under the HSR Act prior to making the
acquisition of CVC voting securities on
November 30, 2010. On February 24,
2012, Dolan made a corrective filing
VerDate Sep<11>2014
16:57 Dec 13, 2018
Jkt 247001
under the HSR Act for the acquisitions
of CVC voting securities, and explained
in a letter accompanying the corrective
filing that his failure to file was
inadvertent. On May 4, 2012, the
Premerger Notification Office of the
Federal Trade Commission notified
Dolan by letter that it would not
recommend a civil penalty for the
violations, but advised Dolan that he
was ‘‘accountable for instituting an
effective program to ensure full
compliance with the Act’s
requirements.’’
III. EXPLANATION OF THE
PROPOSED FINAL JUDGMENT
The proposed Final Judgment
imposes a $609,810 civil penalty
designed to address the violation
alleged in the Complaint and deter the
Defendant and others from violating the
HSR Act. The United States adjusted the
penalty downward from the maximum
permitted under the HSR Act because
the violation was inadvertent, the
Defendant promptly self-reported the
violation after discovery, and the
Defendant is willing to resolve the
matter by consent decree and avoid
prolonged investigation and litigation.
The relief will have a beneficial effect
on competition because the agencies
will be properly notified of future
acquisitions, in accordance with the
law. At the same time, the penalty will
not have any adverse effect on
competition.
IV. REMEDIES AVAILABLE TO
POTENTIAL PRIVATE LITIGANTS
There is no private antitrust action for
HSR Act violations; therefore, entry of
the proposed Final Judgment will
neither impair nor assist the bringing of
any private antitrust action.
V. PROCEDURES AVAILABLE FOR
MODIFICATION OF THE PROPOSED
FINAL JUDGMENT
The United States and the Defendant
have stipulated that the proposed Final
Judgment may be entered by the Court
after compliance with the provisions of
the APPA, provided that the United
States has not withdrawn its consent.
The APPA conditions entry upon the
Court’s determination that the proposed
Final Judgment is in the public interest.
The APPA provides a period of at
least sixty (60) days preceding the
effective date of the proposed Final
Judgment within which any person may
submit to the United States written
comments regarding the proposed Final
Judgment. Any person who wishes to
comment should do so within sixty (60)
days of the date of publication of this
Competitive Impact Statement in the
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Federal Register, or the last date of
publication in a newspaper of the
summary of this Competitive Impact
Statement, whichever is later. All
comments received during this period
will be considered by the United States
Department of Justice, which remains
free to withdraw its consent to the
proposed Final Judgment at any time
prior to the Court’s entry of judgment.
The comments and the response of the
United States will be filed with the
Court. In addition, comments will be
posted on the U.S. Department of
Justice, Antitrust Division’s internet
website and, under certain
circumstances, published in the Federal
Register. Written comments should be
submitted to: Roberta S. Baruch, Special
Attorney, United States, c/o Federal
Trade Commission, 600 Pennsylvania
Avenue, NW, CC–8407, Washington, DC
20580, Email: rbaruch@ftc.gov
The proposed Final Judgment
provides that the Court retains
jurisdiction over this action, and the
parties may apply to the Court for any
order necessary or appropriate for the
modification, interpretation, or
enforcement of the Final Judgment.
VI. ALTERNATIVES TO THE
PROPOSED FINAL JUDGMENT
The United States considered, as an
alternative to the proposed Final
Judgment, a full trial on the merits
against the Defendant. The United
States is satisfied, however, that the
proposed relief is an appropriate
remedy in this matter. Given the facts of
this case, including the Defendant’s selfreporting of the violation and
willingness to promptly settle this
matter, the United States is satisfied that
the proposed civil penalty is sufficient
to address the violation alleged in the
Complaint and to deter violations by
similarly situated entities in the future,
without the time, expense, and
uncertainty of a full trial on the merits.
VII. STANDARD OF REVIEW UNDER
THE APPA FOR THE PROPOSED
FINAL JUDGMENT
The Clayton Act, as amended by the
APPA, requires that proposed consent
judgments in antitrust cases brought by
the United States be subject to a 60-day
comment period, after which the court
shall determine whether entry of the
proposed Final Judgment ‘‘is in the
public interest.’’ 15 U.S.C. § 16(e)(1). In
making that determination, the court, in
accordance with the statute as amended
in 2004, is required to consider:
(A) the competitive impact of such
judgment, including termination of
alleged violations, provisions for
enforcement and modification, duration
E:\FR\FM\14DEN1.SGM
14DEN1
amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 83, No. 240 / Friday, December 14, 2018 / Notices
of relief sought, anticipated effects of
alternative remedies actually
considered, whether its terms are
ambiguous, and any other competitive
considerations bearing upon the
adequacy of such judgment that the
court deems necessary to a
determination of whether the consent
judgment is in the public interest; and
(B) the impact of entry of such
judgment upon competition in the
relevant market or markets, upon the
public generally and individuals
alleging specific injury from the
violations set forth in the complaint
including consideration of the public
benefit, if any, to be derived from a
determination of the issues at trial.
15 U.S.C. § 16(e)(1)(A) & (B). In
considering these statutory factors, the
court’s inquiry is necessarily a limited
one as the government is entitled to
‘‘broad discretion to settle with the
defendant within the reaches of the
public interest.’’ United States v.
Microsoft Corp., 56 F.3d 1448, 1461
(D.C. Cir. 1995); see generally United
States v. SBC Commc’ns, Inc., 489 F.
Supp. 2d 1 (D.D.C. 2007) (assessing
public interest standard under the
Tunney Act); United States v. U.S.
Airways Group, Inc., 38 F. Supp. 3d 69,
75 (D.D.C. 2014) (explaining that the
‘‘court’s inquiry is limited’’ in Tunney
Act settlements); United States v. InBev
N.V./S.A., No. 08-1965 (JR), 2009 U.S.
Dist. LEXIS 84787, at *3 (D.D.C. Aug.
11, 2009) (noting that the court’s review
of a consent judgment is limited and
only inquires ‘‘into whether the
government’s determination that the
proposed remedies will cure the
antitrust violations alleged in the
complaint was reasonable, and whether
the mechanism to enforce the final
judgment are clear and manageable’’).
As the United States Court of Appeals
for the District of Columbia Circuit has
held, under the APPA a court considers,
among other things, the relationship
between the remedy secured and the
specific allegations in the government’s
complaint, whether the decree is
sufficiently clear, whether its
enforcement mechanisms are sufficient,
and whether the decree may positively
harm third parties. See Microsoft, 56
F.3d at 1458–62. With respect to the
adequacy of the relief secured by the
decree, a court may not ‘‘engage in an
unrestricted evaluation of what relief
would best serve the public.’’ United
States v. BNS, Inc., 858 F.2d 456, 462
(9th Cir. 1988) (quoting United States v.
Bechtel Corp., 648 F.2d 660, 666 (9th
Cir. 1981)); see also Microsoft, 56 F.3d
at 1460–62; United States v. Alcoa, Inc.,
152 F. Supp. 2d 37, 40 (D.D.C. 2001);
VerDate Sep<11>2014
16:57 Dec 13, 2018
Jkt 247001
InBev, 2009 U.S. Dist. LEXIS 84787, at
*3. Instead:
[t]he balancing of competing social and
political interests affected by a proposed
antitrust consent decree must be left, in the
first instance, to the discretion of the
Attorney General. The court’s role in
protecting the public interest is one of
insuring that the government has not
breached its duty to the public in consenting
to the decree. The court is required to
determine not whether a particular decree is
the one that will best serve society, but
whether the settlement is ‘‘within the reaches
of the public interest.’’ More elaborate
requirements might undermine the
effectiveness of antitrust enforcement by
consent decree.
Bechtel, 648 F.2d at 666 (emphasis
added) (citations omitted).1
In determining whether a proposed
settlement is in the public interest, a
district court ‘‘must accord deference to
the government’s predictions about the
efficacy of its remedies, and may not
require that the remedies perfectly
match the alleged violations.’’ SBC
Commc’ns, 489 F. Supp. 2d at 17; see
also U.S. Airways, 38 F. Supp. 3d at 74–
75 (noting that a court should not reject
the proposed remedies because it
believes others are preferable and that
room must be made for the government
to grant concessions in the negotiation
process for settlements); Microsoft, 56
F.3d at 1461 (noting the need for courts
to be ‘‘deferential to the government’s
predictions as to the effect of the
proposed remedies’’); United States v.
Archer-Daniels-Midland Co., 272 F.
Supp. 2d 1, 6 (D.D.C. 2003) (noting that
the court should grant ‘‘due respect to
the government’s prediction as to the
effect of proposed remedies, its
perception of the market structure, and
its views of the nature of the case’’). The
ultimate question is whether ‘‘the
remedies [obtained in the decree are] so
inconsonant with the allegations
charged as to fall outside of the ‘reaches
of the public interest.’’’ Microsoft, 56
F.3d at 1461 (quoting United States v.
Western Elec. Co., 900 F.2d 283, 309
(D.C. Cir. 1990)). To meet this standard,
the United States ‘‘need only provide a
factual basis for concluding that the
settlements are reasonably adequate
remedies for the alleged harms.’’ SBC
Commc’ns, 489 F. Supp. 2d at 17.
Moreover, the court’s role under the
APPA is limited to reviewing the
remedy in relationship to the violations
1 See
also BNS, 858 F.2d at 464 (holding that the
court’s ‘‘ultimate authority under the [APPA] is
limited to approving or disapproving the consent
decree’’); United States v. Gillette Co., 406 F. Supp.
713, 716 (D. Mass. 1975) (noting that, in this way,
the court is constrained to ‘‘look at the overall
picture not hypercritically, nor with a microscope,
but with an artist’s reducing glass’’).
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
64363
that the United States has alleged in its
complaint, and does not authorize the
court to ‘‘construct [its] own
hypothetical case and then evaluate the
decree against that case.’’ Microsoft, 56
F.3d at 1459; see also U.S. Airways, 38
F. Supp. 3d at 75 (noting that the court
must simply determine whether there is
a factual foundation for the
government’s decisions such that its
conclusions regarding the proposed
settlements are reasonable); InBev, 2009
U.S. Dist. LEXIS 84787, at *20 (‘‘the
‘public interest’ is not to be measured by
comparing the violations alleged in the
complaint against those the court
believes could have, or even should
have, been alleged’’). Because the
‘‘court’s authority to review the decree
depends entirely on the government’s
exercising its prosecutorial discretion by
bringing a case in the first place,’’ it
follows that ‘‘the court is only
authorized to review the decree itself,’’
and not to ‘‘effectively redraft the
complaint’’ to inquire into other matters
that the United States did not pursue.
Microsoft, 56 F.3d at 1459-60. As a court
in this district confirmed in SBC
Communications, courts ‘‘cannot look
beyond the complaint in making the
public interest determination unless the
complaint is drafted so narrowly as to
make a mockery of judicial power.’’ SBC
Commc’ns, 489 F. Supp. 2d at 15.
In its 2004 amendments,2 Congress
made clear its intent to preserve the
practical benefits of utilizing consent
decrees in antitrust enforcement, adding
the unambiguous instruction that
‘‘[n]othing in this section shall be
construed to require the court to
conduct an evidentiary hearing or to
require the court to permit anyone to
intervene.’’ 15 U.S.C. § 16(e)(2); see also
U.S. Airways, 38 F. Supp. 3d at 76
(indicating that a court is not required
to hold an evidentiary hearing or to
permit intervenors as part of its review
under the Tunney Act). This language
explicitly wrote into the statute what
Congress intended when it first enacted
the Tunney Act in 1974. As Senator
Tunney explained: ‘‘[t]he court is
nowhere compelled to go to trial or to
engage in extended proceedings which
might have the effect of vitiating the
benefits of prompt and less costly
settlement through the consent decree
process.’’ 119 Cong. Rec. 24,598 (1973)
2 The 2004 amendments substituted ‘‘shall’’ for
‘‘may’’ in directing relevant factors for a court to
consider and amended the list of factors to focus on
competitive considerations and to address
potentially ambiguous judgment terms. Compare 15
U.S.C. § 16(e) (2004), with 15 U.S.C. § 16(e)(1)
(2006); see also SBC Commc’ns, 489 F. Supp. 2d at
11 (concluding that the 2004 amendments ‘‘effected
minimal changes’’ to Tunney Act review).
E:\FR\FM\14DEN1.SGM
14DEN1
64364
Federal Register / Vol. 83, No. 240 / Friday, December 14, 2018 / Notices
(statement of Sen. Tunney). Rather, the
procedure for the public interest
determination is left to the discretion of
the court, with the recognition that the
court’s ‘‘scope of review remains
sharply proscribed by precedent and the
nature of Tunney Act proceedings.’’
SBC Commc’ns, 489 F. Supp. 2d at 11.
A court can make its public interest
determination based on the competitive
impact statement and response to public
comments alone. U.S. Airways, 38 F.
Supp. 3d at 76. See also United States
v. Enova Corp., 107 F. Supp. 2d 10, 17
(D.D.C. 2000) (noting that the ‘‘Tunney
Act expressly allows the court to make
its public interest determination on the
basis of the competitive impact
statement and response to comments
alone’’); S. Rep. No. 93–298 93d Cong.,
1st Sess., at 6 (1973) (‘‘Where the public
interest can be meaningfully evaluated
simply on the basis of briefs and oral
arguments, that is the approach that
should be utilized.’’).
VIII. DETERMINATIVE DOCUMENTS
There are no determinative materials
or documents within the meaning of the
APPA that were considered by the
United States in formulating the
proposed Final Judgment.
Date: December 6, 2018 Respectfully
submitted,
_____
Kenneth A. Libby
Special Attorney
U.S. Department of Justice
Antitrust Division
c/o Federal Trade Commission
600 Pennsylvania Avenue, NW
Washington, DC 20580
Phone: (202) 326–2694
Email: klibby@ftc.gov
[FR Doc. 2018–27055 Filed 12–13–18; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Usona
Institute
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 12, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
DATES:
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on October
31, 2018, Usona Institute, 2800 Woods
Hollow Road, Madison, Wisconsin
53711 applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
5-Methoxy-N-N-dimethyltryptamine .................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
The institute plans to manufacture the
listed controlled substances
synthetically in bulk for use in institutesponsored research.
Dated: December 4, 2018.
John J. Martin,
Assistant Administrator.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
amozie on DSK3GDR082PROD with NOTICES1
Importer of Controlled Substances
Application: Arizona Department of
Corrections
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration or the proposed
authorization to import on or before
DATES:
VerDate Sep<11>2014
16:57 Dec 13, 2018
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
[FR Doc. 2018–27132 Filed 12–13–18; 8:45 am]
ACTION:
January 14, 2019. Such persons may
also file a written request for a hearing
on the application for registration and
for authorization to import on or before
January 14, 2019.
Jkt 247001
Pursuant
to 21 U.S.C. 958(i), the Attorney General
shall, prior to issuing a regulation under
21 U.S.C. 952(a)(2)(B) authorizing the
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
7431
7435
Schedule
I
I
importation of a controlled substance in
schedule I or II, provide manufacturers
holding registrations for the bulk
manufacture of the substance an
opportunity for a hearing. Additionally,
pursuant to 21 CFR 1301.34(a), the
Administrator of the Drug Enforcement
Administration (DEA) shall, upon the
filing of an application for registration
to import a controlled substance in
schedule I or II under 21 U.S.C.
952(a)(2)(B), provide notice and the
opportunity to request a hearing to
manufacturers holding registrations for
the bulk manufacture of the substance
and to applicants for such registrations.
The Attorney General has delegated
his authority under the Controlled
Substances Act,1 including the
provisions codified at 21 U.S.C. 952 and
1 The provisions of federal law relating to the
import and export of controlled substances—those
found in 21 U.S.C. 951 through 971—are more
precisely referred to as the Controlled Substances
Import and Export Act. However, federal courts and
DEA often use the term ‘‘Controlled Substances
Act’’ to refer collectively to all provisions from 21
U.S.C. 801 through 971 and, for ease of exposition,
this document will do likewise.
E:\FR\FM\14DEN1.SGM
14DEN1
Agencies
[Federal Register Volume 83, Number 240 (Friday, December 14, 2018)]
[Notices]
[Pages 64359-64364]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27055]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
United States v. James Dolan; Proposed Final Judgment and
Competitive Impact Statement
Notice is hereby given pursuant to the Antitrust Procedures and
Penalties Act, 15 U.S.C. 16(b)-(h), that a proposed Final Judgment,
Stipulation, and Competitive Impact Statement have been filed with the
United States District Court for the District of Columbia in United
States of America v. James Dolan, Civil Action No. 1:18-cv-02858. On
December 6, 2018, the United States filed a Complaint alleging that
James Dolan violated the notice and waiting period requirements of the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, 15 U.S.C. 18a,
with respect to his acquisition of voting securities of Madison Square
Garden Company. The proposed Final Judgment, filed at the same time as
the Complaint, requires James Dolan to pay a civil penalty of $609,810.
Copies of the Complaint, proposed Final Judgment, and Competitive
Impact Statement are available for inspection on the Antitrust
Division's website at https://www.justice.gov/atr and at the Office of
the Clerk of the United States District Court for the District of
Columbia. Copies of these materials may be obtained from the Antitrust
Division upon request and payment of the copying fee set by Department
of Justice regulations.
Public comment is invited within 60 days of the date of this
notice. Such comments, including the name of the submitter, and
responses thereto, will be posted on the Antitrust Division's website,
filed with the Court, and, under certain circumstances, published in
the Federal Register. Comments should be directed to Roberta S. Baruch,
Special Attorney, United States, c/o Federal Trade Commission, 600
Pennsylvania Avenue NW, CC-8416, Washington, DC 20580 (telephone: 202-
326-2861; e-mail: [email protected]).
Patricia A. Brink,
Director of Civil Enforcement.
United States District Court for the District of Columbia
United States of America, c/o Department of Justice, Washington,
D.C. 20530, Plaintiff, v. James L. Dolan, c/o The Madison Square
Garden Company, Two Penn Plaza, New York, NY 10121, Defendant.
Civil Action No. 1:18-cv-02858
COMPLAINT FOR CIVIL PENALTIES FOR FAILURE TO COMPLY WITH THE PREMERGER
REPORTING AND WAITING REQUIREMENTS OF THE HART-SCOTT RODINO ACT
The United States of America, Plaintiff, by its attorneys, acting
under the direction of the Attorney General of the United States and at
the request of the Federal Trade Commission, brings this civil
antitrust action to obtain monetary relief in the form of civil
penalties against Defendant James L. Dolan (``Dolan''). Plaintiff
alleges as follows:
NATURE OF THE ACTION
1. Dolan violated the notice and waiting period requirements of the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, 15 U.S.C. Sec.
18a (``HSR Act'' or ``Act''), with respect to the acquisition of voting
securities of the Madison Square Garden Company (``MSG'') in 2017.
JURISDICTION AND VENUE
2. This Court has jurisdiction over the subject matter of this
action pursuant to Section 7A(g) of the Clayton Act, 15 U.S.C. Sec.
18a(g), and pursuant to 28 U.S.C. Sec. Sec. 1331, 1337(a), 1345, and
1355 and over the Defendant by virtue of Defendant's consent, in the
Stipulation relating hereto, to the maintenance of this action and
entry of the Final Judgment in this District.
3. Venue is properly based in this District by virtue of
Defendant's consent, in the Stipulation relating hereto, to the
maintenance of this action and entry of the Final Judgment in this
District.
THE DEFENDANT
4. Defendant Dolan is a natural person with his principal office
and place of business at Two Penn Plaza, New York, NY 10121. Dolan is
engaged in commerce, or in activities affecting commerce, within the
meaning of Section 1 of the Clayton Act, 15 U.S.C. Sec. 12, and
Section 7A(a)(1) of the Clayton Act, 15 U.S.C. Sec. 18a(a)(1). At all
times relevant to this complaint, Dolan had sales or assets in excess
of $161.5 million.
OTHER ENTITY
5. MSG is a corporation organized under the laws of Delaware with
its principal place of business at Two Penn Plaza, New York, NY 10121.
MSG is engaged in commerce, or in activities affecting commerce, within
the meaning of Section 1 of the Clayton Act, 15 U.S.C. Sec. 12, and
Section 7A(a)(1) of the Clayton Act, 15 U.S.C. Sec. 18a(a)(1). At all
times relevant to this complaint, MSG had sales or assets in excess of
$16.6 million.
THE HART-SCOTT-RODINO ACT AND RULES
6. The HSR Act requires certain acquiring persons and certain
persons whose voting securities or assets are acquired to file
notifications with the Department of Justice and the Federal Trade
Commission (collectively, the ``federal antitrust agencies'') and to
observe a waiting period before consummating certain acquisitions of
voting securities or assets. 15 U.S.C. Sec. 18a(a) and (b). These
notification and waiting period requirements apply to acquisitions that
meet the HSR Act's thresholds, which have been adjusted annually since
2004. The size of transaction threshold is $50 million, as adjusted
($80.8 million for most of 2017). In addition, there is a separate
filing requirement for transactions in which the acquirer will hold
voting securities in excess of $100 million, as adjusted ($161.5
million in 2017), and for transactions in which the acquirer will hold
voting securities in excess of $500 million, as adjusted ($807.5
million in 2017). With respect to the size of person thresholds, the
HSR Act requires one person involved in the transaction to have sales
or assets in excess of $10 million, as adjusted ($16.6 million in
2017), and the other person to have sales or assets in excess of $100
million, as adjusted ($161.5 million in 2017).
7. The HSR Act's notification and waiting period requirements are
[[Page 64360]]
intended to give the federal antitrust agencies prior notice of, and
information about, proposed transactions. The waiting period is also
intended to provide the federal antitrust agencies with an opportunity
to investigate a proposed transaction and to determine whether to seek
an injunction to prevent the consummation of a transaction that may
violate the antitrust laws.
8. Pursuant to Section (d)(2) of the HSR Act, 15 U.S.C. Sec.
18a(d)(2), rules were promulgated to carry out the purposes of the HSR
Act. 16 C.F.R. Sec. Sec. 801-03 (``HSR Rules''). The HSR Rules, among
other things, define terms contained in the HSR Act.
9. Pursuant to section 801.13(a)(1) of the HSR Rules, 16 C.F.R.
Sec. 801.13(a)(1), ``all voting securities of [an] issuer which will
be held by the acquiring person after the consummation of an
acquisition''--including any held before the acquisition--are deemed
held ``as a result of'' the acquisition at issue.
10. Pursuant to sections 801.13(a)(2) and 801.10(c)(1) of the HSR
Rules, 16 C.F.R. Sec. 801.13(a)(2) and Sec. 801.10(c)(1), the value
of voting securities already held is the market price, defined to be
the lowest closing price within 45 days prior to the subsequent
acquisition.
11. Section 802.21 of the HSR Rules, 16 C.F.R. Sec. 802.21,
provides that once a person has filed under the HSR Act and the waiting
period has expired, the person can acquire additional voting securities
of the issuer without making a new filing for five years from the
expiration of the waiting period, so long as the holdings do not exceed
a higher threshold than was indicated in the filing.
12. Section 7A(g)(1) of the Clayton Act, 15 U.S.C. Sec. 18a(g)(1),
provides that any person, or any officer, director, or partner thereof,
who fails to comply with any provision of the HSR Act is liable to the
United States for a civil penalty for each day during which such person
is in violation. Pursuant to the Federal Civil Penalties Inflation
Adjustment Act Improvements Act of 2015, Pub. L. 114-74, Sec. 701
(further amending the Federal Civil Penalties Inflation Adjustment Act
of 1990), and Federal Trade Commission Rule 1.98, 16 C.F.R. Sec. 1.98,
83 Fed. Reg. 2902 (January 22, 2018), the maximum amount of civil
penalty is currently $41,484 per day.
DEFENDANT'S PRIOR VIOLATION OF THE HSR ACT
13. On March 10, 2010, Dolan acquired voting securities of
Cablevision Systems Corporation (``CVC'') that resulted in holdings
exceeding the adjusted $50 million threshold then in effect under the
HSR Act. Although he was required to do so, Dolan did not file under
the HSR Act prior to acquiring CVC voting securities on March 10, 2010.
14. Subsequently, Dolan made additional acquisitions of CVC voting
securities such that on November 30, 2010 his holdings exceeded the
adjusted $100 million threshold then in effect under the HSR Act.
Although he was required to do so, Dolan did not file under the HSR Act
prior to making the acquisition of CVC voting securities on November
30, 2010.
15. On February 24, 2012, Dolan made a corrective filing under the
HSR Act for the acquisitions of CVC voting securities. In a letter
accompanying the corrective filing, Dolan acknowledged that the
transactions were reportable under the HSR Act, but asserted that the
failure to file and observe the waiting period was inadvertent.
16. On May 4, 2012, the Premerger Notification Office of the
Federal Trade Commission sent a letter to Dolan indicating that it
would not recommend a civil penalty action regarding the March 10,
2010, and November 30, 2010, CVC acquisitions. The letter advised,
however, that Dolan ``still must bear responsibility for compliance
with the Act'' and was ``accountable for instituting an effective
program to ensure full compliance with the Act's requirements.''
DEFENDANT'S VIOLATION OF THE HSR ACT
17. Dolan is the Executive Chairman and a Director of MSG and, as a
result of holding these positions, frequently receives restricted stock
units (``RSUs'') as a part of his compensation package. On August 16,
2016, due to vesting RSUs, Dolan filed an HSR Notification for an
acquisition of MSG voting securities that would result in holdings
exceeding the $50 million threshold as adjusted. Early termination of
the HSR Act's waiting period was granted on this filing on September 6,
2016, and Dolan completed the acquisition three days later. Dolan was
permitted under the HSR Act to acquire additional voting securities of
MSG without making another HSR Act filing so long as he did not exceed
the $100 million threshold, as adjusted. As of February 27, 2017, the
adjusted $100 million threshold was $161.5 million.
18. On September 11, 2017, Dolan acquired 591 shares of MSG due to
vesting RSUs. As a result of this acquisition, Dolan held voting
securities of MSG valued in excess of the $161.5 million threshold then
in effect.
19. Although required to do so, Dolan did not file under the HSR
Act or observe the HSR Act's waiting period prior to completing the
September 11, 2017, transaction.
20. On November 24, 2017, Dolan made a corrective filing and the
waiting period expired on December 26, 2017. Dolan was in continuous
violation of the HSR Act from September 11, 2017, when he acquired the
MSG voting securities valued in excess of the HSR Act's then applicable
$100 million filing threshold, as adjusted ($161.5 million), through
December 26, 2017, when the waiting period expired on his corrective
filing.
REQUESTED RELIEF
WHEREFORE, Plaintiff requests:
a. That the Court adjudge and decree that Defendant's acquisition
of MSG voting securities on September 11, 2017, was a violation of the
HSR Act, 15 U.S.C. Sec. 18a; and that Defendant was in violation of
the HSR Act each day from September 11, 2017, through December 26,
2017;
b. That the Court order Defendant to pay to the United States an
appropriate civil penalty as provided by the HSR Act, 15 U.S.C. Sec.
18a(g)(1), and the Federal Civil Penalties Inflation Adjustment Act
Improvements Act of 2015, Pub. L. 114-74, Sec. 701 (further amending
the Federal Civil Penalties Inflation Adjustment Act of 1990), and
Federal Trade Commission Rule 1.98, 16 C.F.R. Sec. 1.98, 83 Fed. Reg.
2902 (January 22, 2018);
c. That the Court order such other and further relief as the Court
may deem just and proper; and
d. That the Court award Plaintiff its costs of this suit.
Dated:
-----------------------------------------------------------------------
FOR THE PLAINTIFF UNITED STATES OF AMERICA:
-----------------------------------------------------------------------
Makin Delrahim, D.C. Bar No. 457795, Assistant Attorney General,
Department of Justice,
Antitrust Division,
Washington, D.C. 20530
-----------------------------------------------------------------------
Roberta S. Baruch, D.C. Bar No. 269266,
Special Attorney.
-----------------------------------------------------------------------
Kenneth A. Libby, Special Attorney.
-----------------------------------------------------------------------
Jennifer Lee, Special Attorney,
Federal Trade Commission,
[[Page 64361]]
Washington, D.C. 20530,
(202) 326-2694.
United States District Court for the District of Columbia
United States of America, Plaintiff, v. James L. Dolan,
Defendant.
Civil Action No. 1:18-cv-02858
[PROPOSED] FINAL JUDGMENT
Plaintiff, the United States of America, having commenced this
action by filing its Complaint herein for violation of Section 7A of
the Clayton Act, 15 U.S.C. Sec. 18a, commonly known as the
Hart[dash]Scott[dash]Rodino Antitrust Improvements Act of 1976, and
Plaintiff and Defendant James L. Dolan, by their respective attorneys,
having consented to the entry of this Final Judgment without trial or
adjudication of any issue of fact or law herein, and without this Final
Judgment constituting any evidence against or an admission by the
Defendant with respect to any such issue:
NOW, THEREFORE, before the taking of any testimony and without
trial or adjudication of any issue of fact or law herein, and upon the
consent of the parties hereto, it is hereby
ORDERED, ADJUDGED, AND DECREED:
The Court has jurisdiction of the subject matter of this action and
of the Plaintiff and the Defendant. The Complaint states a claim upon
which relief can be granted against the Defendant under Section 7A of
the Clayton Act, 15 U.S.C. Sec. 18a.
II.
Judgment is hereby entered in this matter in favor of Plaintiff and
against Defendant, and, pursuant to Section 7A(g)(1) of the Clayton
Act, 15 U.S.C. Sec. 18a(g)(1), the Debt Collection Improvement Act of
1996, Pub. L. 104[dash]134 Sec. 31001(s) (amending the Federal Civil
Penalties Inflation Adjustment Act of 1990, 28 U.S.C. Sec. 2461), the
Federal Civil Penalties Inflation Adjustment Act Improvements Act of
2015, Pub. L. 114-74 Sec. 701 (further amending the Federal Civil
Penalties Inflation Adjustment Act of 1990), and Federal Trade
Commission Rule 1.98, 16 C.F.R. Sec. 1.98, 82 Fed. Reg. 8135 (January
24, 2017), Defendant is hereby ordered to pay a civil penalty in the
amount of six hundred nine thousand eight hundred and ten dollars
($609,810). Payment of the civil penalty ordered hereby shall be made
by wire transfer of funds or cashier's check. If the payment is made by
wire transfer, Defendant shall contact Janie Ingalls of the Antitrust
Division's Antitrust Documents Group at (202) 514-2481 for instructions
before making the transfer. If the payment is made by cashier's check,
the check shall be made payable to the United States Department of
Justice and delivered to: Janie Ingalls, United States Department of
Justice, Antitrust Division, Antitrust Documents Group, 450 5th Street,
NW, Suite 1024, Washington, D.C. 20530
Defendant shall pay the full amount of the civil penalty within
thirty (30) days of entry of this Final Judgment. In the event of a
default or delay in payment, interest at the rate of eighteen (18)
percent per annum shall accrue thereon from the date of the default or
delay to the date of payment.
III.
Each party shall bear its own costs of this action.
IV.
This Final Judgment shall expire upon payment in full by the
Defendant of the civil penalty required by Section II of this Final
Judgment.
V.
Entry of this Final Judgment is in the public interest. The parties
have complied with the requirements of the Antitrust Procedures and
Penalties Act, 15 U.S.C. Sec. 16, including making copies available to
the public of this Final Judgment, the Competitive Impact Statement,
and any comments thereon and the United States' responses to comments.
Based upon the record before the Court, which includes the Competitive
Impact Statement and any comments and response to comments filed with
the Court, entry of this Final Judgment is in the public interest.
Dated:
-----------------------------------------------------------------------
United States District Judge
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
United States of America, Plaintiff, v. James L. Dolan, Defendant.
Civil Action No. 1:18-cv-02858
COMPETITIVE IMPACT STATEMENT
Plaintiff United States of America (``United States''), pursuant to
Section 2(b) of the Antitrust Procedures and Penalties Act (``APPA''),
15 U.S.C. Sec. 16(b)-(h), files this Competitive Impact Statement
relating to the proposed Final Judgment submitted for entry in this
civil antitrust proceeding.
I. NATURE AND PURPOSE OF THE PROCEEDING
On December 6, 2018, the United States filed a Complaint against
Defendant James L. Dolan (``Dolan''), related to Dolan's acquisitions
of voting securities of the Madison Square Garden Company (``MSG'') in
September 2017. The Complaint alleges that Dolan violated Section 7A of
the Clayton Act, 15 U.S.C. Sec. 18a, commonly known as the Hart-Scott-
Rodino Antitrust Improvements Act of 1976 (the ``HSR Act''). The HSR
Act provides that ``no person shall acquire, directly or indirectly,
any voting securities of any person'' exceeding certain thresholds
until that person has filed pre-acquisition notification and report
forms with the Department of Justice and the Federal Trade Commission
(collectively, the ``federal antitrust agencies'' or ``agencies'') and
the post-filing waiting period has expired. 15 U.S.C. Sec. 18a(a). A
key purpose of the notification and waiting period requirements is to
protect consumers and competition from potentially anticompetitive
transactions by providing the agencies an opportunity to conduct an
antitrust review of proposed transactions before they are consummated.
The Complaint alleges that Dolan acquired voting securities of MSG
in excess of then-applicable statutory threshold ($161.5 million at the
time of acquisition) without making the required pre-acquisition HSR
Act filings with the agencies and without observing the waiting period,
and that Dolan and MSG met the applicable statutory size of person
thresholds.
At the same time the Complaint was filed in the present action, the
United States also filed a Stipulation and proposed Final Judgment that
eliminates the need for a trial in this case. The proposed Final
Judgment is designed to address the violation alleged in the Complaint
and deter Dolan's HSR Act violations. Under the proposed Final
Judgment, Dolan must pay a civil penalty to the United States in the
amount of $609,810.
The United States and the Defendant have stipulated that the
proposed Final Judgment may be entered after compliance with the APPA,
unless the United States first withdraws its consent. Entry of the
proposed Final Judgment would terminate this case, except that the
Court would retain jurisdiction to construe, modify, or enforce the
provisions of the proposed Final Judgment and punish violations
thereof.
II. DESCRIPTION OF THE EVENTS GIVING RISE TO THE ALLEGED VIOLATION
Dolan is the Executive Chairman and a Director of MSG and an
investor. At all times relevant to the Complaint,
[[Page 64362]]
Dolan had sales or assets in excess of $161.5 million. At all times
relevant to the Complaint, MSG had sales or assets in excess of $16.6
million.
In his roles as Executive Chairman and Director of MSG, Dolan
frequently receives restricted stock units (``RSUs'') as a part of his
compensation package. On August 16, 2016, due to the imminent vesting
of RSUs, Dolan made an HSR filing for an acquisition of MSG voting
securities that would result in holdings exceeding the adjusted $50
million threshold then in effect. The Premerger Notification Office
granted early termination on this filing on September 6, 2016, and
Dolan completed the acquisition three days later. For a period of five
years, Dolan was permitted under the HSR Act to acquire additional
voting securities of MSG without making another HSR Act filing so long
as he did not exceed the $100 million threshold, as adjusted. As of
February 27, 2017, the adjusted $100 million threshold was $161.5
million.
On September 11, 2017, Dolan acquired 591 shares of MSG due to
vesting RSUs. As a result of this acquisition, Dolan held voting
securities of MSG valued in excess of the $161.5 million threshold then
in effect. Although he was required to do so, Dolan did not file under
the HSR Act or observe the HSR Act's waiting period prior to completing
the September 11, 2017, transaction.
Dolan made a corrective HSR Act filing on November 27, 2017, after
learning that this acquisition was subject to the HSR Act's
requirements and that he was obligated to file. The waiting period for
that corrective filing expired on December 26, 2017.
The Complaint further alleges that Dolan's September 2017 HSR Act
violation was not the first time Dolan had failed to observe the HSR
Act's notification and waiting period requirements. On March 10, 2010,
Dolan acquired voting securities of Cablevision Systems Corporation
(``CVC'') that resulted in holdings exceeding the adjusted $50 million
threshold then in effect under the HSR Act. Although he was required to
do so, Dolan did not file under the HSR Act prior to acquiring CVC
voting securities on March 10, 2010. Subsequently, Dolan made
additional acquisitions of CVC voting securities such that on November
30, 2010 his holdings exceeded the adjusted $100 million threshold then
in effect under the HSR Act. Although he was required to do so, Dolan
did not file under the HSR Act prior to making the acquisition of CVC
voting securities on November 30, 2010. On February 24, 2012, Dolan
made a corrective filing under the HSR Act for the acquisitions of CVC
voting securities, and explained in a letter accompanying the
corrective filing that his failure to file was inadvertent. On May 4,
2012, the Premerger Notification Office of the Federal Trade Commission
notified Dolan by letter that it would not recommend a civil penalty
for the violations, but advised Dolan that he was ``accountable for
instituting an effective program to ensure full compliance with the
Act's requirements.''
III. EXPLANATION OF THE PROPOSED FINAL JUDGMENT
The proposed Final Judgment imposes a $609,810 civil penalty
designed to address the violation alleged in the Complaint and deter
the Defendant and others from violating the HSR Act. The United States
adjusted the penalty downward from the maximum permitted under the HSR
Act because the violation was inadvertent, the Defendant promptly self-
reported the violation after discovery, and the Defendant is willing to
resolve the matter by consent decree and avoid prolonged investigation
and litigation. The relief will have a beneficial effect on competition
because the agencies will be properly notified of future acquisitions,
in accordance with the law. At the same time, the penalty will not have
any adverse effect on competition.
IV. REMEDIES AVAILABLE TO POTENTIAL PRIVATE LITIGANTS
There is no private antitrust action for HSR Act violations;
therefore, entry of the proposed Final Judgment will neither impair nor
assist the bringing of any private antitrust action.
V. PROCEDURES AVAILABLE FOR MODIFICATION OF THE PROPOSED FINAL JUDGMENT
The United States and the Defendant have stipulated that the
proposed Final Judgment may be entered by the Court after compliance
with the provisions of the APPA, provided that the United States has
not withdrawn its consent. The APPA conditions entry upon the Court's
determination that the proposed Final Judgment is in the public
interest.
The APPA provides a period of at least sixty (60) days preceding
the effective date of the proposed Final Judgment within which any
person may submit to the United States written comments regarding the
proposed Final Judgment. Any person who wishes to comment should do so
within sixty (60) days of the date of publication of this Competitive
Impact Statement in the Federal Register, or the last date of
publication in a newspaper of the summary of this Competitive Impact
Statement, whichever is later. All comments received during this period
will be considered by the United States Department of Justice, which
remains free to withdraw its consent to the proposed Final Judgment at
any time prior to the Court's entry of judgment. The comments and the
response of the United States will be filed with the Court. In
addition, comments will be posted on the U.S. Department of Justice,
Antitrust Division's internet website and, under certain circumstances,
published in the Federal Register. Written comments should be submitted
to: Roberta S. Baruch, Special Attorney, United States, c/o Federal
Trade Commission, 600 Pennsylvania Avenue, NW, CC-8407, Washington, DC
20580, Email: [email protected]
The proposed Final Judgment provides that the Court retains
jurisdiction over this action, and the parties may apply to the Court
for any order necessary or appropriate for the modification,
interpretation, or enforcement of the Final Judgment.
VI. ALTERNATIVES TO THE PROPOSED FINAL JUDGMENT
The United States considered, as an alternative to the proposed
Final Judgment, a full trial on the merits against the Defendant. The
United States is satisfied, however, that the proposed relief is an
appropriate remedy in this matter. Given the facts of this case,
including the Defendant's self-reporting of the violation and
willingness to promptly settle this matter, the United States is
satisfied that the proposed civil penalty is sufficient to address the
violation alleged in the Complaint and to deter violations by similarly
situated entities in the future, without the time, expense, and
uncertainty of a full trial on the merits.
VII. STANDARD OF REVIEW UNDER THE APPA FOR THE PROPOSED FINAL JUDGMENT
The Clayton Act, as amended by the APPA, requires that proposed
consent judgments in antitrust cases brought by the United States be
subject to a 60-day comment period, after which the court shall
determine whether entry of the proposed Final Judgment ``is in the
public interest.'' 15 U.S.C. Sec. 16(e)(1). In making that
determination, the court, in accordance with the statute as amended in
2004, is required to consider:
(A) the competitive impact of such judgment, including termination
of alleged violations, provisions for enforcement and modification,
duration
[[Page 64363]]
of relief sought, anticipated effects of alternative remedies actually
considered, whether its terms are ambiguous, and any other competitive
considerations bearing upon the adequacy of such judgment that the
court deems necessary to a determination of whether the consent
judgment is in the public interest; and
(B) the impact of entry of such judgment upon competition in the
relevant market or markets, upon the public generally and individuals
alleging specific injury from the violations set forth in the complaint
including consideration of the public benefit, if any, to be derived
from a determination of the issues at trial.
15 U.S.C. Sec. 16(e)(1)(A) & (B). In considering these statutory
factors, the court's inquiry is necessarily a limited one as the
government is entitled to ``broad discretion to settle with the
defendant within the reaches of the public interest.'' United States v.
Microsoft Corp., 56 F.3d 1448, 1461 (D.C. Cir. 1995); see generally
United States v. SBC Commc'ns, Inc., 489 F. Supp. 2d 1 (D.D.C. 2007)
(assessing public interest standard under the Tunney Act); United
States v. U.S. Airways Group, Inc., 38 F. Supp. 3d 69, 75 (D.D.C. 2014)
(explaining that the ``court's inquiry is limited'' in Tunney Act
settlements); United States v. InBev N.V./S.A., No. 08-1965 (JR), 2009
U.S. Dist. LEXIS 84787, at *3 (D.D.C. Aug. 11, 2009) (noting that the
court's review of a consent judgment is limited and only inquires
``into whether the government's determination that the proposed
remedies will cure the antitrust violations alleged in the complaint
was reasonable, and whether the mechanism to enforce the final judgment
are clear and manageable'').
As the United States Court of Appeals for the District of Columbia
Circuit has held, under the APPA a court considers, among other things,
the relationship between the remedy secured and the specific
allegations in the government's complaint, whether the decree is
sufficiently clear, whether its enforcement mechanisms are sufficient,
and whether the decree may positively harm third parties. See
Microsoft, 56 F.3d at 1458-62. With respect to the adequacy of the
relief secured by the decree, a court may not ``engage in an
unrestricted evaluation of what relief would best serve the public.''
United States v. BNS, Inc., 858 F.2d 456, 462 (9th Cir. 1988) (quoting
United States v. Bechtel Corp., 648 F.2d 660, 666 (9th Cir. 1981)); see
also Microsoft, 56 F.3d at 1460-62; United States v. Alcoa, Inc., 152
F. Supp. 2d 37, 40 (D.D.C. 2001); InBev, 2009 U.S. Dist. LEXIS 84787,
at *3. Instead:
[t]he balancing of competing social and political interests
affected by a proposed antitrust consent decree must be left, in the
first instance, to the discretion of the Attorney General. The
court's role in protecting the public interest is one of insuring
that the government has not breached its duty to the public in
consenting to the decree. The court is required to determine not
whether a particular decree is the one that will best serve society,
but whether the settlement is ``within the reaches of the public
interest.'' More elaborate requirements might undermine the
effectiveness of antitrust enforcement by consent decree.
Bechtel, 648 F.2d at 666 (emphasis added) (citations omitted).\1\
\1\ See also BNS, 858 F.2d at 464 (holding that the court's
``ultimate authority under the [APPA] is limited to approving or
disapproving the consent decree''); United States v. Gillette Co.,
406 F. Supp. 713, 716 (D. Mass. 1975) (noting that, in this way, the
court is constrained to ``look at the overall picture not
hypercritically, nor with a microscope, but with an artist's
reducing glass'').
---------------------------------------------------------------------------
In determining whether a proposed settlement is in the public
interest, a district court ``must accord deference to the government's
predictions about the efficacy of its remedies, and may not require
that the remedies perfectly match the alleged violations.'' SBC
Commc'ns, 489 F. Supp. 2d at 17; see also U.S. Airways, 38 F. Supp. 3d
at 74-75 (noting that a court should not reject the proposed remedies
because it believes others are preferable and that room must be made
for the government to grant concessions in the negotiation process for
settlements); Microsoft, 56 F.3d at 1461 (noting the need for courts to
be ``deferential to the government's predictions as to the effect of
the proposed remedies''); United States v. Archer-Daniels-Midland Co.,
272 F. Supp. 2d 1, 6 (D.D.C. 2003) (noting that the court should grant
``due respect to the government's prediction as to the effect of
proposed remedies, its perception of the market structure, and its
views of the nature of the case''). The ultimate question is whether
``the remedies [obtained in the decree are] so inconsonant with the
allegations charged as to fall outside of the `reaches of the public
interest.''' Microsoft, 56 F.3d at 1461 (quoting United States v.
Western Elec. Co., 900 F.2d 283, 309 (D.C. Cir. 1990)). To meet this
standard, the United States ``need only provide a factual basis for
concluding that the settlements are reasonably adequate remedies for
the alleged harms.'' SBC Commc'ns, 489 F. Supp. 2d at 17.
Moreover, the court's role under the APPA is limited to reviewing
the remedy in relationship to the violations that the United States has
alleged in its complaint, and does not authorize the court to
``construct [its] own hypothetical case and then evaluate the decree
against that case.'' Microsoft, 56 F.3d at 1459; see also U.S. Airways,
38 F. Supp. 3d at 75 (noting that the court must simply determine
whether there is a factual foundation for the government's decisions
such that its conclusions regarding the proposed settlements are
reasonable); InBev, 2009 U.S. Dist. LEXIS 84787, at *20 (``the `public
interest' is not to be measured by comparing the violations alleged in
the complaint against those the court believes could have, or even
should have, been alleged''). Because the ``court's authority to review
the decree depends entirely on the government's exercising its
prosecutorial discretion by bringing a case in the first place,'' it
follows that ``the court is only authorized to review the decree
itself,'' and not to ``effectively redraft the complaint'' to inquire
into other matters that the United States did not pursue. Microsoft, 56
F.3d at 1459-60. As a court in this district confirmed in SBC
Communications, courts ``cannot look beyond the complaint in making the
public interest determination unless the complaint is drafted so
narrowly as to make a mockery of judicial power.'' SBC Commc'ns, 489 F.
Supp. 2d at 15.
In its 2004 amendments,\2\ Congress made clear its intent to
preserve the practical benefits of utilizing consent decrees in
antitrust enforcement, adding the unambiguous instruction that
``[n]othing in this section shall be construed to require the court to
conduct an evidentiary hearing or to require the court to permit anyone
to intervene.'' 15 U.S.C. Sec. 16(e)(2); see also U.S. Airways, 38 F.
Supp. 3d at 76 (indicating that a court is not required to hold an
evidentiary hearing or to permit intervenors as part of its review
under the Tunney Act). This language explicitly wrote into the statute
what Congress intended when it first enacted the Tunney Act in 1974. As
Senator Tunney explained: ``[t]he court is nowhere compelled to go to
trial or to engage in extended proceedings which might have the effect
of vitiating the benefits of prompt and less costly settlement through
the consent decree process.'' 119 Cong. Rec. 24,598 (1973)
[[Page 64364]]
(statement of Sen. Tunney). Rather, the procedure for the public
interest determination is left to the discretion of the court, with the
recognition that the court's ``scope of review remains sharply
proscribed by precedent and the nature of Tunney Act proceedings.'' SBC
Commc'ns, 489 F. Supp. 2d at 11. A court can make its public interest
determination based on the competitive impact statement and response to
public comments alone. U.S. Airways, 38 F. Supp. 3d at 76. See also
United States v. Enova Corp., 107 F. Supp. 2d 10, 17 (D.D.C. 2000)
(noting that the ``Tunney Act expressly allows the court to make its
public interest determination on the basis of the competitive impact
statement and response to comments alone''); S. Rep. No. 93-298 93d
Cong., 1st Sess., at 6 (1973) (``Where the public interest can be
meaningfully evaluated simply on the basis of briefs and oral
arguments, that is the approach that should be utilized.'').
---------------------------------------------------------------------------
\2\ The 2004 amendments substituted ``shall'' for ``may'' in
directing relevant factors for a court to consider and amended the
list of factors to focus on competitive considerations and to
address potentially ambiguous judgment terms. Compare 15 U.S.C.
Sec. 16(e) (2004), with 15 U.S.C. Sec. 16(e)(1) (2006); see also
SBC Commc'ns, 489 F. Supp. 2d at 11 (concluding that the 2004
amendments ``effected minimal changes'' to Tunney Act review).
---------------------------------------------------------------------------
VIII. DETERMINATIVE DOCUMENTS
There are no determinative materials or documents within the
meaning of the APPA that were considered by the United States in
formulating the proposed Final Judgment.
Date: December 6, 2018 Respectfully submitted,
_____
Kenneth A. Libby
Special Attorney
U.S. Department of Justice
Antitrust Division
c/o Federal Trade Commission
600 Pennsylvania Avenue, NW
Washington, DC 20580
Phone: (202) 326-2694
Email: [email protected]
[FR Doc. 2018-27055 Filed 12-13-18; 8:45 am]
BILLING CODE 6750-01-P